FDA Awards Breakthrough Designation to Pi-Cardia’s ShortCut Catheter
ShortCut is the first dedicated leaflet modification device to enable TAVR in patients at risk of coronary obstruction, according to Pi-Cardia.
ShortCut is the first dedicated leaflet modification device to enable TAVR in patients at risk of coronary obstruction, according to Pi-Cardia.